NRAS and acute myeloid leukemia: Moreover, in an MDS study, the results indicated that NRAS, KRAS, PTPN11, and FLT3 mutations promote the transformation of MDS, while NPM1, WT1, and IDH2 mutations were common in MDS‐transformed s‐AML.38